LeukoVantage: A Quest/QIAGEN Partnership Providing Clinical Insights Into Myeloid Malignancies

In this webinar, we will describe Quest’s LeukoVantage assay, an NGS test designed specifically for detecting clinically relevant variants in myeloid malignancies, and its partnership with N-of-One, a QIAGEN company, for expert interpretation.

Quantitative, Reproducible, Standardized, and Scalable – Needs for Translational Proteomics

This webinar will discuss new technology developments and optimization of each component in the translational proteomics workflow.
video

Genetics of Neurodegenerative Disorders – How Mutations Affect Disease Pathology

This webinar highlights current research of the APOE gene, and how its E4 allele affects disease pathology in Alzheimer’s disease.
video

Multiplexed IHC/ISH Using an Automated Slide Staining Platform

New equipment and methodologies have allowed researchers to streamline their IHC and ISH workflows.
video

Addressing Challenges of NGS Data Interpretation for Hematologic Malignancies

This groundbreaking webinar will discuss how NGS technologies have aided clinicians in the diagnosis and treatment of hematologic cancer.
Protein (ubiquitin) molecule (cartoon model). Stylized image.

In-Cell Protein Footprinting: A New Tool for Proteome-Wide Structural Biology

VIEW NOW Broadcast Date: June 26, 2019 Time: 8:00 am PT, 11:00 am ET, 17:00 CET Protein structure must be studied in its native cellular environment, otherwise,...
video

Target Enrichment Technology Optimized for Analysis of SNPs, Mutations, and Copy Number Changes in...

During this webinar we will describe and present data for an NGS target enrichment workflow, based on the novel SPET.

Advancing Mass Spectrometry-Based Large-Cohort Proteomics for Precision Medicine

Large cohort studies are essential to the discovery of protein biomarkers, and their validation is indispensable to clinical utility.

Liquid Biopsy and ddPCR: A Match with Quality in Mind

In this webinar we will hear how GenQA addresses some of the challenges in providing quality assessments for ctDNA testing.

The Year in CRISPRs

2015 was a phenomenal year full of new developments for the structures and mechanisms of CRISPR systems.
Scroll Up